Findings showed treatment with semaglutide 1mg reduced the risk of kidney-disease progression as well as cardiovascular and kidney death by 24% compared with placebo. Treatment with semaglutide ...
Please provide your email address to receive an email when new articles are posted on . The ADA 84th Scientific Sessions will kick off Friday in Orlando. New data on tirzepatide, semaglutide, inhaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback